Publications

Found 1 results
Filters: Author is Y.-S. Zhao  [Clear All Filters]
2011
J. Feng, Li, L., Zhao, Y. - S., Tang, S. - Q., Yang, H. - B., and Liu, S. - X., Interaction between CYP 2C19*3 polymorphism and smoking in relation to laryngeal carcinoma in the Chinese Han population, vol. 10, pp. 3331-3337, 2011.
Ashfield-Watt PA, Welch AA, Day NE and Bingham SA (2004). Is 'five-a-day' an effective way of increasing fruit and vegetable intakes? Publ. Health Nutr. 7: 257-261. http://dx.doi.org/10.1079/PHN2003524 PMid:15003132   Cikojević D, Gluncić I and Klancnik M (2010). Cigarette smoking and progression of laryngeal lesions. Coll. Antropol. 34 (Suppl 1): 45-48. PMid:20402295   Ercan B, Ayaz L, Cicek D and Tamer L (2008). Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem. Funct. 26: 309-313. http://dx.doi.org/10.1002/cbf.1437 PMid:17868191   Fava C, Montagnana M, Almgren P, Rosberg L, et al. (2008). The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 52: 373-380. http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.114199 PMid:18574070   Fichtlscherer S, Dimmeler S, Breuer S, Busse R, et al. (2004). Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 109: 178-183. http://dx.doi.org/10.1161/01.CIR.0000105763.51286.7F PMid:14662709   Gauthier KM, Falck JR, Reddy LM and Campbell WB (2004). 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol. Res. 49: 515-524. http://dx.doi.org/10.1016/j.phrs.2003.09.014 PMid:15026029   Imig JD (2000). Epoxygenase metabolites. Epithelial and vascular actions. Mol. Biotechnol. 16: 233-251. http://dx.doi.org/10.1385/MB:16:3:233   Jiang JG, Chen CL, Card JW, Yang S, et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 65: 4707-4715. http://dx.doi.org/10.1158/0008-5472.CAN-04-4173 PMid:15930289   Jiang JG, Ning YG, Chen C, Ma D, et al. (2007). Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res. 67: 6665-6674. http://dx.doi.org/10.1158/0008-5472.CAN-06-3643 PMid:17638876   Kurahashi K, Nishihashi T, Trandafir CC, Wang AM, et al. (2003). Diversity of endothelium-derived vasocontracting factors-arachidonic acid metabolites. Acta Pharmacol. Sin. 24: 1065-1069. PMid:14627486   Lundell K and Wikvall K (2008). Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr. Drug Metab. 9: 323-331. http://dx.doi.org/10.2174/138920008784220574 PMid:18473750   Node K, Ruan XL, Dai J, Yang SX, et al. (2001). Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J. Biol. Chem. 276: 15983-15989. http://dx.doi.org/10.1074/jbc.M100439200 PMid:11279071   Sun J, Sui X, Bradbury JA, Zeldin DC, et al. (2002). Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ. Res. 90: 1020-1027. http://dx.doi.org/10.1161/01.RES.0000017727.35930.33 PMid:12016269   Ye YN, Liu ES, Shin VY, Wu WK, et al. (2004). Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J. Pharmacol. Exp. Ther. 308: 66-72. http://dx.doi.org/10.1124/jpet.103.058321 PMid:14569062